Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes

Br J Haematol. 2017 Feb;176(3):491-495. doi: 10.1111/bjh.13968. Epub 2016 Feb 23.
No abstract available

Keywords: EPO receptor; TFR2; erythroid response; erythropoietin; myelodysplastic syndromes.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Bone Marrow Cells / metabolism*
  • Bone Marrow Cells / pathology
  • Erythropoietin / biosynthesis*
  • Erythropoietin / genetics
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes / blood
  • Myelodysplastic Syndromes / genetics
  • Myelodysplastic Syndromes / metabolism*
  • Myelodysplastic Syndromes / pathology
  • Prognosis
  • Receptors, Transferrin / biosynthesis*
  • Receptors, Transferrin / genetics
  • Retrospective Studies

Substances

  • Receptors, Transferrin
  • TFR2 protein, human
  • Erythropoietin